These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
117 related items for PubMed ID: 3948928
1. Development of latent residual drug damage to the hematopoietic marrow during the subsequent growth of tumors. Kovacs CJ, Johnke RM, Evans MJ, Emma DA, Hooker JL. Exp Hematol; 1986 Mar; 14(3):165-72. PubMed ID: 3948928 [Abstract] [Full Text] [Related]
3. Long-term consequences of chemotherapeutic agents on hematopoiesis: development of altered radiation tolerance. Kovacs CJ, Evans MJ, Hooker JL, Johnke RM. NCI Monogr; 1988 Mar; (6):45-9. PubMed ID: 3352788 [Abstract] [Full Text] [Related]
4. Long-term marrow cultures from mice with busulfan-induced chronic latent aplasia. Halka KG, Caro J, Erslev AJ. J Lab Clin Med; 1987 Jun; 109(6):698-705. PubMed ID: 3585143 [Abstract] [Full Text] [Related]
5. Bone marrow connexin-43 expression is critical for hematopoietic regeneration after chemotherapy. Presley CA, Lee AW, Kastl B, Igbinosa I, Yamada Y, Fishman GI, Gutstein DE, Cancelas JA. Cell Commun Adhes; 2005 Jun; 12(5-6):307-17. PubMed ID: 16531325 [Abstract] [Full Text] [Related]
13. Tumor-associated surface membrane antigens on CFUs: characterization using the fluorescent activated cell sorter. Hasthorpe S, Rogerson J. Exp Hematol; 1982 Jan; 10(1):9-19. PubMed ID: 7060662 [Abstract] [Full Text] [Related]
14. Restrictions in the stem cell function of murine bone marrow grafts after ex vivo expansion of short-term repopulating progenitors. Varas F, Bernard A, Bueren JA. Exp Hematol; 1998 Feb; 26(2):100-9. PubMed ID: 9472799 [Abstract] [Full Text] [Related]
15. Differential cytotoxic activity of chemotherapy agents on colony-forming cells from human tumors and normal bone marrow in vitro. Ajani JA, Blaauw AA, Spitzer G, Baker FL, Tomasovic B, Umbach G, Thielvoldt D, Zander AR, Dicke KA. Exp Hematol; 1985 Feb; 13 Suppl 16():95-100. PubMed ID: 2580731 [Abstract] [Full Text] [Related]
16. Contrasting mechanisms of the myeloprotective effects of interleukin-1 against ionizing radiation and cytotoxic 5-fluorouracil. Neta R, Keller JR, Ali N, Blanchette F, Dubois CM. Radiat Res; 1996 May; 145(5):624-31. PubMed ID: 8619029 [Abstract] [Full Text] [Related]
17. AM5, a protein-associated polysaccharide, stimulates hematopoiesis and modulates the expression of endogenous hematopoietic growth factors in murine long-term bone marrow cultures. Güenechea G, Bueren JA, Maganto G, Tuduri P, Guerrero A, Pivel JP, Real A. Stem Cells; 1995 Mar; 13(2):175-85. PubMed ID: 7540471 [Abstract] [Full Text] [Related]
18. Prevention of acute chemotherapy-induced death in mice by recombinant human interleukin 1: protection from hematological and nonhematological toxicities. Damia G, Komschlies KL, Futami H, Back T, Gruys ME, Longo DL, Keller JR, Ruscetti FW, Wiltrout RH. Cancer Res; 1992 Aug 01; 52(15):4082-9. PubMed ID: 1638519 [Abstract] [Full Text] [Related]
19. Thy-1 antigen expression by murine high-proliferative capacity hematopoietic progenitor cells. I. Relation between sensitivity to depletion by Thy-1 antibody and stem cell generation potential. Boswell HS, Wade PM, Quesenberry PJ. J Immunol; 1984 Dec 01; 133(6):2940-9. PubMed ID: 6149245 [Abstract] [Full Text] [Related]
20. Haemopoietic stem cells: possibility of toxic effects of 5-fluorouracil on spleen colony formation. Rosendaal M, Dixon R, Panayi M. Blood Cells; 1981 Dec 01; 7(3):561-74. PubMed ID: 7337836 [Abstract] [Full Text] [Related] Page: [Next] [New Search]